2022 | Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial | Nguyen, Trong Toan; Chiu, Cheng-Hsun; Lin, Chien-Yu; Chiu, Nan-Chang; Chen, Po-Yen; Le, Thi Tuong Vy; Le, Dang Ngan; Duong, An Han; Nguyen, Van Luan; Huynh, Thi Nguyet; Truong, Huu Khanh; Phan, Trong Lan; Nguyen, Thi Thanh Thao; Shih, Shin-Ru; Huang, Chung-Guei; Weng, Yi-Jen; Hsieh, Erh-Fang; Chang, Stanley; Chen, Charles; Tai, I-Chen; LI-MIN HUANG | Lancet (London, England) | 18 | 14 | |
2022 | Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders | PO-HAN LIN ; Tseng, Ling-Ming; Lee, Yi-Hsuan; Chen, Shou-Tung; Yeh, Dah-Cherng; Dai, Ming-Shen; Liu, Liang-Chih; MING-YANG WANG ; Chiao Lo ; Chang, Stanley; Tan, Kien Thiam; Chen, Shu-Jen; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Journal of the Formosan Medical Association | 6 | 4 | |
2023 | Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial | Heo, Jeong; JA-DER LIANG ; Kim, Chang Won; Woo, Hyun Young; I-LUN SHIH ; TUNG-HUNG SU ; ZHONG-ZHE LIN ; Yoo, So Young; Chang, Stanley; Urata, Yasuo; PEI-JER CHEN | Molecular therapy : the journal of the American Society of Gene Therapy | 4 | 1 | |